Is Narayana Hrudayalaya (NH) overvalued or fairly valued?

MarketChacha shows Narayana Hrudayalaya's valuation in context — a forward P/E of about 28.1, a price-to-book of about 8.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Narayana Hrudayalaya's revenue?

Narayana Hrudayalaya reported revenue of ₹7,896 Cr for FY2026, with net profit of ₹806 Cr, per official filings.

What is the share price of Narayana Hrudayalaya (NH)?

Narayana Hrudayalaya last traded at ₹1,968.00 (-2.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Narayana Hrudayalaya

NH · NSE · Healthcare · India

₹1,968.00-2.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 9:59 AM

Snapshot

TickerNH

ExchangeNSE

SectorHealthcare

IndustryMedical Care Facilities

CountryIndia

HeadquartersBengaluru, India

Market cap₹39,970 Cr

P/B8.8

Volume2.89L

Websitewww.narayanahealth.org

Filings tracked0

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters67.2%
Institutions13.1%
Public & other19.7%

82 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 3.2 points over the period — profitability is trending down.

Net margin trend13.4% → 10.2%

Margin has compressed by about 3.2 points over the period — profitability is trending down.

Growth qualityrev 20% · PAT 10%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹2,524 Cr · EPS 14.00

Est. earnings growth +10.2%

Next fiscal year

Rev ₹12,000 Cr · EPS 70.14

Est. earnings growth +22.9%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹1,589.0052-wk range₹2,093.30

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹39,970 Cr

Day change

-2.9%

Fwd P/E

28.1

P/B

8.8

Div yield

0.23%

Beta

0.18

Revenue (FY2026)

₹7,896 Cr

Net margin

10.2%

Revenue CAGR (3y)

+20.4%

Profit CAGR (3y)

+9.9%

Net profit (FY2026)

₹806 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about NH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹7,896 Cr	₹806 Cr	10.2%
FY2025	₹5,617 Cr	₹790 Cr	14.1%
FY2024	₹5,018 Cr	₹789 Cr	15.7%
FY2023	₹4,525 Cr	₹606 Cr	13.4%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹2,594 Cr	₹224 Cr	8.6%
2025Q4	₹2,151 Cr	₹127 Cr	5.9%
2025Q3	₹1,644 Cr	₹258 Cr	15.7%
2025Q2	₹1,507 Cr	₹197 Cr	13.0%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.